EUVIMEDEUVIMED entdecken
KorrekturOpen Access · CC BY 4.0

Correction: RPL28 mediates sorafenib resistance in hepatocellular carcinoma by downregulating CDC6 expression

Yi Shi, Fangfang Chen, Yuanyuan Weng, Hang Zeng, Gang Chen

Frontiers in Oncology · 04.03.2026 · 16

DOI: 10.3389/fonc.2026.1814738 ↗

Kurz gefasst

Korrektur in der Zeitschrift Frontiers in Oncology, online erschienen am 04.03.2026. Verfasst von Yi Shi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Pathology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, China. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

CDC6hepatocellular carcinomaproteomeribosomal proteins L28 (RPL28)sorafenib resistancetranscriptome

Autor:innen und Institutionen

  • Department of Molecular Pathology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, China.
  • Department of Pathology, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian, China.

Zitieren

APA

Shi, Y., Chen, F., Weng, Y., Zeng, H., & Chen, G. (2026). Correction: RPL28 mediates sorafenib resistance in hepatocellular carcinoma by downregulating CDC6 expression. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1814738

Vancouver

Shi Y, Chen F, Weng Y, Zeng H, Chen G. Correction: RPL28 mediates sorafenib resistance in hepatocellular carcinoma by downregulating CDC6 expression. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1814738

BibTeX
@article{Shi2026,
  author = {Shi, Yi and Chen, Fangfang and Weng, Yuanyuan and Zeng, Hang and Chen, Gang},
  title = {Correction: RPL28 mediates sorafenib resistance in hepatocellular carcinoma by downregulating CDC6 expression},
  journal = {Frontiers in Oncology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fonc.2026.1814738}
}
Kostenlos starten →